Phytohealth Corp Total Assets

Latest as of June 2026: NT$2.41 Billion TWD ≈ $75.98 Million USD

Phytohealth Corp total assets. Based on the latest financial reports, Phytohealth Corp (4108) holds total assets worth NT$2.41 Billion TWD (≈ $75.98 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Phytohealth Corp market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Phytohealth Corp (2002–2025)

Total assets of Phytohealth Corp from 2002 to 2025. This chart illustrates how Phytohealth Corp's total assets have evolved over time, based on quarterly financial data. See Phytohealth Corp share price for real-time trading data and today's change.

Phytohealth Corp - Asset Composition Analysis

Phytohealth Corp Total Assets Breakdown (December 2025)

Phytohealth Corp total assets breakdown as of December 2025. Phytohealth Corp's total assets of NT$2.41 Billion consist of 53.7% current assets and 46.3% non-current assets.

Asset Category Amount (TWD) % of Total Assets
Cash & Equivalents NT$0.00 3.7%
Accounts Receivable NT$36.36 Million 1.6%
Inventory NT$126.08 Million 5.4%
Property, Plant & Equipment NT$0.00 0.0%
Intangible Assets NT$28.83 Million 1.2%
Goodwill NT$31.18 Million 1.3%

Asset Composition Trend (2002–2025)

This chart illustrates how Phytohealth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Phytohealth Corp to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Phytohealth Corp's current assets represent 53.7% of total assets in 2025, an increase from 0.0% in 2002.
  • Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, down from 27.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2002.
  • Asset Diversification: The largest asset category is inventory at 5.4% of total assets.

Phytohealth Corp Competitors by Total Assets

Key competitors of Phytohealth Corp based on total assets are shown below.

Company Country Total Assets
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Galderma Group N
SW:GALD
Switzerland CHF12.88 Billion
Enzymatica publ AB
ST:ENZY
Sweden Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Walvax BioTech
SHE:300142
China CN¥10.50 Billion

Phytohealth Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 29.17 37.31 25.77
Quick Ratio 26.44 33.70 23.33
Cash Ratio 0.00 0.00 0.00
Working Capital NT$1.14 Billion NT$1.46 Billion NT$1.59 Billion

Phytohealth Corp - Advanced Valuation Insights

This section examines the relationship between Phytohealth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.20
Latest Market Cap to Assets Ratio 0.03
Asset Growth Rate (YoY) -3.5%
Total Assets NT$2.35 Billion
Market Capitalization $70.40 Million USD

Valuation Analysis

Below Book Valuation: The market values Phytohealth Corp's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Phytohealth Corp's assets decreased by 3.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Phytohealth Corp (2002–2025)

The table below shows the annual total assets of Phytohealth Corp from 2002 to 2025.

Year Total Assets Change
2025-12-31 NT$2.35 Billion
≈ $74.13 Million
-3.55%
2024-12-31 NT$2.44 Billion
≈ $76.86 Million
+3.79%
2023-12-31 NT$2.35 Billion
≈ $74.05 Million
-0.60%
2022-12-31 NT$2.36 Billion
≈ $74.50 Million
-4.27%
2021-12-31 NT$2.47 Billion
≈ $77.82 Million
+36.50%
2020-12-31 NT$1.81 Billion
≈ $57.01 Million
-3.84%
2019-12-31 NT$1.88 Billion
≈ $59.29 Million
-9.01%
2018-12-31 NT$2.07 Billion
≈ $65.16 Million
-5.65%
2017-12-31 NT$2.19 Billion
≈ $69.07 Million
-9.60%
2016-12-31 NT$2.42 Billion
≈ $76.40 Million
+3.64%
2015-12-31 NT$2.34 Billion
≈ $73.72 Million
-6.00%
2014-12-31 NT$2.49 Billion
≈ $78.42 Million
-11.85%
2013-12-31 NT$2.82 Billion
≈ $88.97 Million
-2.06%
2012-12-31 NT$2.88 Billion
≈ $90.84 Million
+74.70%
2011-12-31 NT$1.65 Billion
≈ $52.00 Million
-13.45%
2010-12-31 NT$1.91 Billion
≈ $60.08 Million
-9.79%
2009-12-31 NT$2.11 Billion
≈ $66.60 Million
+96.20%
2008-12-31 NT$1.08 Billion
≈ $33.94 Million
-30.74%
2007-12-31 NT$1.56 Billion
≈ $49.01 Million
+15.04%
2006-12-31 NT$1.35 Billion
≈ $42.60 Million
+11.66%
2005-12-31 NT$1.21 Billion
≈ $38.15 Million
+296.80%
2004-12-31 NT$305.18 Million
≈ $9.61 Million
-11.31%
2003-12-31 NT$344.09 Million
≈ $10.84 Million
+120.54%
2002-12-31 NT$156.02 Million
≈ $4.92 Million
--

About Phytohealth Corp

TW:4108 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$70.40 Million
NT$2.23 Billion TWD
Market Cap Rank
#20395 Global
#1222 in Taiwan
Share Price
NT$11.25
Change (1 day)
-0.88%
52-Week Range
NT$10.75 - NT$15.25
All Time High
NT$46.36
About

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more